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A role for TSPO in mitochondrial Ca2+ homeostasis and
redox stress signaling
Jemma Gatliff1,7, Daniel A East1,2,7, Aarti Singh1, Maria Soledad Alvarez1, Michele Frison1,3, Ivana Matic4, Caterina Ferraina2,4,
Natalie Sampson5, Federico Turkheimer3 and Michelangelo Campanella*,1,4,6
The 18 kDa translocator protein TSPO localizes on the outer mitochondrial membrane (OMM). Systematically overexpressed at
sites of neuroinflammation it is adopted as a biomarker of brain conditions. TSPO inhibits the autophagic removal of mitochondria
by limiting PARK2-mediated mitochondrial ubiquitination via a peri-organelle accumulation of reactive oxygen species (ROS). Here
we describe that TSPO deregulates mitochondrial Ca2+ signaling leading to a parallel increase in the cytosolic Ca2+ pools that
activate the Ca2+-dependent NADPH oxidase (NOX) thereby increasing ROS. The inhibition of mitochondrial Ca2+ uptake by TSPO
is a consequence of the phosphorylation of the voltage-dependent anion channel (VDAC1) by the protein kinase A (PKA), which is
recruited to the mitochondria, in complex with the Acyl-CoA binding domain containing 3 (ACBD3). Notably, the neurotransmitter
glutamate, which contributes neuronal toxicity in age-dependent conditions, triggers this TSPO-dependent mechanism of cell
signaling leading to cellular demise. TSPO is therefore proposed as a novel OMM-based pathway to control intracellular Ca2+
dynamics and redox transients in neuronal cytotoxicity.
Cell Death and Disease (2017) 8, e2896; doi:10.1038/cddis.2017.186; published online 22 June 2017
TSPO initially characterized as the peripheral binding site
for the benzodiazepines1,2 complexes with the voltage-
dependent anion channel (VDAC).3 Even though questioned,
the role of TSPO in transporting cholesterol into mitochondria
for steroidogenesis4–6 remains the best-characterized one.7
TSPO, which is ubiquitously expressed throughout the
peripheral tissues although at various levels8 is almost absent
in healthy adult brain,9 to instead accumulate in age-related
degenerative disorders10 and traumatic stress.11
Binding of TSPO is largely developed in diagnostic studies
of neuroinflammation following successful protocols of posi-
tive emission tomography (PET).12 TSPO is therefore amen-
able to noninvasive diagnostic routines as well as to chemical
targeting, thus making pivotal a comprehensive characteriza-
tion of its molecular physiology for broader applications.
The binding of TSPO to VDAC, which is the principal Ca2+
channel of the OMM,13 could imply modifications in the
homeostasis of this second messenger that contributes the
inflammasome.14 Previous reports have shown that TSPO
ligands modulate mitochondrial and cytosolic Ca2+
dynamics15,16 as well as that TSPO itself impairs cellular
mitophagy17 questioning whether it has a direct or indirect role
in mitochondrial and cell signaling regulation. TSPO interacts
with the Acyl-CoA binding domain containing 3 protein
(ACBD3)18 that complexes with the cAMP-dependent protein
kinase (PKA)19 which, via phosphorylation,20 regulates VDAC
activity.
We have therefore formulated a working hypothesis
whereby the overexpression of TSPO, induced during cellular
stress, may be functionally relevant to Ca2+ homeostasis and
cell signaling by anchoring the ACBD3/PKA complex on the
mitochondria and therefore primes VDAC post-translational
modifications.
Here, we have tested this using various approaches to
finally propose a model, which sees TSPO as an inducible,
OMM-based conduit, to control intracellular Ca2+ dynamics,
redox transients and cytotoxicity.
Results
The Ca2+-dependent NADPH oxidase drives TSPO-
associated ROS. We previously ascribed the inhibition of
cellular mitophagy by TSPO to ROS microdomains that
prevent the in situ ubiquitination for autophagic removal.17
The increased accumulation of cytosolic ROS following
overexpression of TSPO – previously reported17 – was here
confirmed in the neuronal cell line SH-SY5Y overex-
pressing TSPO (+TSPO; Figure 1a depicts transient over-
expression of the protein with densitometry analysis reported
in Figure 1b, MOCK-transfected cells (hereafter referred to as
Control unless otherwise stated): 1.00±0.00; +TSPO:
1.65± 0.1).
The increased ROS levels were reduced by KN93 (10 μM),
an inhibitor of the Ca2+/Calmodulin-dependent protein kinase
(CaMK) II21 which is pivotal for the activation of the NADPH
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oxidase (NOX)22,23 (traces reported in Figure 1c and rate of
ROS increase in Figure 1d Control: 0.028±0.008; +TSPO:
0.058± 0.003; Control +KN93: 0.017±0.007; +TSPO +KN93:
0.022± 0.001). This implied events occurring downstream of
the mobilization of intracellular Ca2+, which were therefore
inferred pharmacologically by repeating the analysis in the
presence of the specific NOX inhibitors DPI (diphenyleneio-
donium) and Apocynin (200 nM)24 (Figure 1e and f).
1.65±0.1
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Both inhibitors, consistent with the KN93 data, lowered
cytosolic ROS levels in +TSPO conditions thus implying
a link with the Ca2+-dependent NOX-originated ROS
(DPI, Control: 0.11± 0.03; +TSPO: 0.26± 0.04; Control
+DPI: 0.12±0.05; +TSPO +DPI: 0.08±0.0; Apocynin,
Control: 0.028± 0.008; +TSPO: 0.058± 0.003; Control
+Apocynin: 0.018± 0.008; +TSPO +Apocynin: 0.027±
0.009). The NOX family of superoxide (O2
•− ) and hydrogen
peroxide (H2O2) producing proteins are indeed an important
source of ROS in signal transduction.25
NOX proteins are composed of various isoforms, of which
the isoform 5 is activated by Ca2+ and Calmodulin-based
mechanisms26,27 as it contains EF-hand Ca2+-binding
domains28,29 and therefore being sensitive to increases in
the [Ca2+]i. Interestingly, TSPO has been recently proposed to
interplay with NOX proteins.30 To ascertain this and corrobo-
rate the pharmacological evidences implying a correlation
between TSPO, Ca2+ and ROS producing NOX proteins, we
generated a SH-SY5Y cell line stably downregulated for
TSPO (SH-TSPOkd hereafter referred to as −TSPO;
protein expression levels, Control: 1.00±0.00; −TSPO:
0.016±0.004; Figures 1g, h, Supplementary Figures 1a and
b), which had markedly reduced levels of ROS if compared
with control (Control: 1; non-silencing (NSC): 0.99±0.004;
−TSPO: 0.078±0.03; Figure 1i). Notably, the mRNA analysis
of NOX isoforms revealed a significant, specific, reduction in
the expression of the isoform 5 (Figure 1j; −TSPO, p22phox:
0.77±0.021 NOX2/DUOX2: 0.73± 0.0021 NOX4:
1.08±0.001 NOX5: 0.39±0.004).
To validate this further, we created a SH-SY5Y cell line
stably downregulated for NOX5 (Figure 1k; mRNA, Control:
1.±0.3; −NOX5: 0.52±0.1) in which we measured ROS
levels following recombinant overexpression of TSPO that did
not increase above control levels (Figure 1l; DHE rate of
increase, Control: 1; −NOX5: 1.1±0.29). Having recorded
that the TSPO-mediated accumulation of ROS is dependent
on NOX signaling and likely via the Ca2+-dependent isoform,
we thoroughly investigated the Ca2+ homeostasis.
TSPO alters Ca2+ dynamics mammalian cells. To inves-
tigate the role of TSPO in Ca2+ signaling, MEFs with silenced
TSPO were co-transfected with mitochondria-targeted
aequorin (mtAEQ) – a Ca2+-sensitive photoprotein31 and
perfused with ATP (1 mM). The resulting Ca2+ response was
calibrated to quantify [Ca2+]m,
31 which resulted which
resulted in elevated levels of Ca2+ in TSPO knockdown
(−TSPO) MEFs (Figure 2a), with a mitochondrial [Ca2+]max of
132.2±9.4 compared with Control values of 89.78±12.2
(Figure 2b). Non-silencing TSPO shRNA (NSTPSO) was
tested too and compared with Control and mtAEQ solely
expressing MEFs (Supplementary Figure 1c). We also
assessed the effects in wild-type TSPO-overexpressing
cells (+TSPO) or expressing the mutant isoform of
TSPO (+TSPOΔ) bearing a deletion of the cholesterol
binding motif.32 In both these conditions, [Ca2+]m was
significantly impaired, indicating that TSPO-mediated Ca2+
regulation is independent from the cholesterol binding
function (+TSPO: 32.10±9.4; +TSPOΔ: 46.97±2.36;
Figures 2a and b). Comparable results were obtained
in HeLa (Supplementary Figures 1d and e) and canine
epithelial cells (CF35; Supplementary Figures 2a
and b), a microglia cell line (BV2) and primary rat microglia
cultures (Supplementary Figures 2f–h) suggesting a con-
served regulatory mechanism. The differences observed in
mitochondrial Ca2+ handling were also consistent with
changes in the mitochondrial membrane potential (ΔΨm)
recorded in −TSPO cells (Supplementary Figures 3a and b).
We therefore assessed the cytoplasmic Ca2+ transients,
using MEFs transfected with cytoplasmic-targeted aequorin
(cytAEQ)33 reporting that the [Ca2+]c was decreased in
−TSPO cells (2.43±0.25) compared with Control
(4.31± 0.14), while significantly higher transients were
observed in both +TSPO (6.70±0.10) and +TSPOΔ cells
(9.58± 0.55; Figure 2d). Also in this case, reciprocity of results
was obtained in HeLa (Supplementary Figures 1f and g) and
CF35 cells (Supplementary Figures 2c–e).
A well-established factor in the Ca2+ homeostasis is that
alterations in the mitochondrial Ca2+ buffering capacity would
subsequently shape the amplitude of the cytosolic signal.31,32
To confirm this specific correlation also in cells expressing
alternative TSPO levels, we used thapsigargin (Tg),34 which
inhibits the sarco-endoplasmic reticulum Ca2+-ATPase
(SERCA), leading to an IP3 independent rise in [Ca
2+]c
through proton-leakage channels.35 Using a fluorescence-
based approach, we found that in −TSPO cells Tg elicited a
significantly greater rise in mitochondrial Ca2+ level as
determined by Rhod-2 Fmax (1.89± 0.11) compared with
the Control (0.73±0.12) and +TSPO (0.58±0.10;
Figures 2e and f).
The same experiment performed in the cytosolic compart-
ment demonstrated that overexpression of TSPO led to
increased [Ca2+]c (0.89±0.08) compared with Control
(0.81± 0.04), whereas TSPO knockdown restricted this rise
(0.57± 0.04; Figures 2g and h). TSPO may indeed control
mitochondrial Ca2+ uptake rather than influencing the levels of
Ca2+ stored in the ER or Ca2+ influx across the plasma
Figure 1 TSPO-associated ROS is derived from Ca2+-dependent NADPH oxidase. (a) Western blot showing TSPO overexpression in SH-SY5Y. (b) Quantification of TSPO
overexpression. (c) Representative dihydroethidium (DHE) traces of TSPO knockdown SH-SY5Y cells in the presence of KN93. (d) Corresponding bar chart showing mean rate
of increase in dihydroethidium fluorescence intensity; n= 3 (⩾30 cells per field of analysis); Po0.001. (e) Bar chart showing the rate of increase in DHE fluorescence intensity in
+TSPO cells treated with DPI (200 nM). (f) Bar chart showing the rate of increase in dihyroethidum fluorescence intensity in +TSPO cells treated with Apocynin (200 nM).
(g) Western blot showing TSPO knockdown in SH-SY5Y cells (n= 4, ⩾ 50 cells per field of analysis, Po0.001); (h) quantification of TSPO expression in SH-SY5Y cells (n= 2,
⩾ 50 cells per field of analysis, Po0.001). (i) Bar chart showing the rate of increase in DHE fluorescence intensity in − TSPO cells (n= 2, ⩾ 50 cells per field of analysis,
Po0.001). (j) qRT-PCR studies of NOX isoforms in SH-SY5Y (Po0.001). (k) qRT-PCR study of NOX expression in control and NOX5 KD cells showing fold change in gene
expression (n= 3, Po0.001). (l) Bar chart showing the rate of increase in DHE fluorescence intensity in NOX5 KD cells (n= 3, ⩾ 40 cells per field of analysis, P40.05;
**Po0.01, ***Po0.001)
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Figure 2 TSPO re-routes cellular Ca2+ signals in mammalian cells. (a) Representative Ca2+ transients from MEFs transfected with mtAeq and stimulated with ATP (1 μM). (b)
Graph showing the mean max [Ca2+]m n= 5;⩾ 50 cells per field of analysis; Po0.05. (c) Representative Ca2+ transients from MEFs transfected with cytAeq and stimulated with
ATP (1 mM). (d) Graph showing the mean max [Ca2+]c n= 3;⩾ 50 cells per field of analysis; Po0.05. (e) Representative mitochondrial Ca2+ traces obtained in MEFs loaded with
Rhod-2 and stimulated with Thapsigargin (100 nM). (f) Graph showing mean maximum Rhod-2 fluorescence intensity in MEFs. n= 4; ⩾ 40 cells per field of analysis; Po0.001.
(g) Representative cytosolic Ca2+ traces obtained in CF35 cells loaded with Fluo-4 and stimulated with Thapsigargin (100 nM). (h) Graph showing mean maximum Fluo-4
fluorescence intensity in MEFs (n= 3; ⩾ 40 cells per field of analysis; Po0.001). (i) Mean intensity of DHE fluorescence between control and TSPO-KD cells treated with
Thapsigargin (*Po0.05, **Po0.01, ***Po0.001)
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Figure 3 TSPO alters mitochondrial network morphology but not ER-mitochondria connectivity. (a) Representative mid-plane cross-sectional images of the cellular mitochondrial
network obtained through confocal microscopy are depicted in the left panel. White boxes show regions of the cell that are then magnified in the right panel. (b) Bar chart showing the
mean aspect ratio of mitochondria according to TSPO expression (n415 cells; Po0.001). (c) Bar chart showing the mean form factor for mitochondria according to TSPO expression;
n415 cells; Po0.001. (d) Electromicrographs showing ER-mitochondria adjacency (e) Representative confocal image of which the green signal is indicative of ER-green and the red
signal represents the mitochondrial network. Areas of mitochondria that overlap with the ER are colored yellow. (f) Manders’ coefficient M1, calculated by volume of ER in contact with
mitochondria/ total volume of ER; n45 cells; P40.05. (g) Graph showing how the Manders’ coefficient M2, calculated by volume of mitochondria in contact with ER/total volume of
mitochondria, varies according to TSPO expression. Graph shows the % mitochondria connected with the ER; n45 cells; P40.05. (h) Panel depicts mitoKeima measurement of
mitophagy repression in SH-SY5Y cells expressing TSPO in alternative amount. (i) Mitophagy Index expressed as mitoKeima fluorescence ratio is quantified (*Po0.05, ***Po0.001)
Cell signalling regulation by TSPO
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membrane, thus influencing the tonicity of the cytosolic
Ca2+ signals and the generation of ROS. The rate of ROS
accumulation in SH-SY5Y cells is thus reduced, following
depletion of Ca2+ from the intracellular stores via treatment
with Tg and reduced further by TSPO deletion (Control:
1.03±0.05 Control Tg: 0.85±0.05 −TSPO: 0.78±0.04
−TSPO Tg: 0.68± 0.04; Figure 2i).
TSPO alters mitochondrial network morphology but not
the ER-mitochondria connectivity. Alterations in mito-
chondrial Ca2+ uptake pathways may be linked to morpho-
logical changes in the mitochondrial network. We therefore
scrutinized mitochondrial morphology by analyzing images
from cells expressing mitochondrial-targeted GFP, (mtGFP;17
Figure 3a). The mitochondrial aspect ratio, a measure of
length and form factor and the degree of branching, revealed
a tendency for the mitochondrial network in −TSPO cells to
be longer (Figure 3b) and more branched (Figure 3c) than
NSTSPO (which was used as Control as not bearing
alterations, please see Supplementary Figure 3c), while
shorter and less-branched networks were observed in
+TSPO cells, consistent with our analysis on TSPO and
Ca2+ handling. We have previously shown that TSPO
expression level does not correlate to the levels of the pro-
fission and pro-fusion proteins,17 although activation of DRP1
can be Ca2+-dependent.36
There is a well-established structural and functional
coupling between the ER and mitochondrial network37 in
which VDACs are found at higher densities38 and they are
involved in ER-mitochondria tethering promoting mitochon-
drial Ca2+ uptake.39 We therefore explored whether altering
TSPO/VDAC expression ratio may impact upon
ER-mitochondria connectivity. Electron Micrograph evaluation
of the adjacency between ER and mitochondria (Figure 3d)
indicated that any TSPO-mediated alteration of Ca2+ signaling
is independent from ER-mitochondria physical coupling. To
corroborate this further, however, three-dimensional images
were generated from cells double stained for the ER (Green,
using ER Tracker Green) and mitochondria (Red, using the
mtRFP; Figure 3e) thus allowing the determination of the
coefficients of co-localization and overlap between the two
signals.40 In the M1 cohort (indicating the fraction of the ER
that co-localizes with mitochondria), TSPO expression level
did not alter the level of interaction between mitochondria and
ER (Figure 3f). There was a marginal increase in the +TSPO
condition (0.77±0.04) compared with both NSTPO
(0.64±0.08) and −TSPO (0.63± 0.03) but this was not
statistically significant (Figure 3f). Similarly, in the M2 cohort
(indicating the fraction of mitochondria that co-localizes with
the ER), TSPO expression level did not yield any significant
difference (NSTPO: 0.52±0.06; +TSPO: 0.55± 0.05;
−TSPO: 0.52 ±0.01; Figure 3g). Increased TSPO/VDAC1
ratio inactivates the PARK2-mediated ubiquitination of mito-
chondrial proteins and the execution of mitophagy.17 Repre-
sentative micrographs of mitophagy were acquired via
confocal microscopy using the dual emission of the ratiometric
pH-sensitive fluorescent protein mt-Keima41 in neuronal cells
(SH-SY5Y) exposed to FCCP (1 μM; Figure 3h). High ratio
543 nm/458 nm fluorescence ratio indicates mitochondria in
acidic lysosomes resulting from their autophagic removal. As
quantified in Figure 3i, this mitophagy index is reduced in
TSPO-overexpressing cells (NSTPO: 1; +TSPO: 0.32±
0.001, n=2), while greatly increased when the protein is
ablated (NSTSPO: 1;−TSPO: 1.65±0.003, n= 2). Also in this
case, NSTSPO was used as control (Supplementary
Figure 3d).
Furthermore, in VDAC1 knockout MEFs (VDAC1− /−), the
mitochondrial network appears larger (Supplementary
Figure 3e) similar to what is observed during TSPO over-
expression confirming that, it is the TSPO ratio with VDAC1
the core variable in defining mitochondrial structure and
function.
TSPO-dependent regulation of Ca2+ is via VDAC1 and the
PKA. The results on ER-mitochondria contact sites led us to
investigate alternative regulatory pathways via which TSPO
may impinge on intercellular Ca2+ signaling.
The uptake of Ca2+ across the inner mitochondrial
membrane (IMM) is dependent on the mitochondrial Ca2+
uniporter (MCU).42 To understand whether TSPO could be
acting at this level, we verified the impact of TSPO expression
modulation on the MCU transcription. Quantitative real-time
RT-PCR was performed42 on samples extracted from TSPO-
silenced MEFs with no differences recorded (Control:
0.19±0.01, +TSPO: 0.20± 0.01, −TSPO: 0.18± 0.02, non-
silencing control (NSC): 0.21± 0.02, +TSPOΔ150–158:
0.23±0.03; Figure 4a).
We subsequently knocked down MCU in MEFs (qRT-PCR
NSC: 0.26±0.02, −MCU: 0.19±0.02, Figure 4b, western
blotting analyses in Figures 4d and e) and checked whether
this had effect on TSPO expression per se, which did not
(NSC: 0.21±0.04, −MCU: 0.22±0.03, Figure 4c).
Mitochondrial Ca2+ uptake was then assessed in MCU/
TSPO-silenced MEFs by using the mAeq.31 As expected,
knocking down of MCU resulted in a significant decrease of
the mitochondrial Ca2+ capacity (38.81±1.2 μM) compared
with NSC (89.78± 12.2 μM; Figures 4f and g). Interestingly,
when TSPO expression was also suppressed, mitochondrial
Ca2+ uptake was partially rescued (58.68± 1.2 μM; Figures 4f
and g). By reducing TSPO expression and therefore increas-
ing the amount of Ca2+ within the intermembrane space, the
lower levels of MCU might still be active and therefore permit
influx of Ca2+ into thematrix, leading to a partial recovery of the
mitochondrial Ca2+ uptake capacity.
As TSPO interacts with VDAC1, which is the principal Ca2+
channel of the OMM,43,44 we measured ATP-induced mito-
chondrial Ca2+ uptake in TSPO-silenced VDAC1 knockout
MEFs (VDAC1− /− MEFs45). In these cells, modulation of
TSPO failed to alter the ATP-induced [Ca2+]m signal thus
indicating that VDAC1 is essential for its effects on [Ca2+]m
(representative traces reported in Figure 4h and quantified
data in I, data are μM Ca2+, VDAC1− /−: 47.09± 7.9;
VDAC1− /− +TSPO: 54.09± 11.4; VDAC1− /− −TSPO:
50.15±7.4; VDAC1− /− +VDAC1: 106.6± 24.8; n44;
Po0.05). Still, the actual regulatory pattern remained elusive.
Though, it was previously demonstrated that VDAC1 can be
phosphorylated by the PKA46 leading to reduction in VDAC1
conductance.47 Equally, it was also shown that TSPO forms a
macromolecular complex with the ACBD3, PKA and VDAC1
on the OMM.48 To pharmacologically test whether PKA
Cell signalling regulation by TSPO
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Figure 4 TSPO-dependent Ca2+ regulation occurs at the OMM and requires VDAC1 and PKA. (a) Real-time qRT-PCR studies show mRNA levels of MCU, normalized to
levels of VDAC in MEFs; n= 3; P40.05. (b) Real-time qRT-PCR studies show mRNA levels of MCU, normalized to levels of VDAC in MEFs with modulated MCU expression;
n= 7; ***Po0.001. (c) Real-time qRT-PCR studies show mRNA levels of TSPO, normalized to levels of VDAC in MEFs with modulated MCU expression, n= 5. (d and e)
Immunoblot of MCU in MEFs WT and knocked out for the gene with quantification in e. (f) Representative traces showing ATP-induced mitochondrial Ca2+ uptake in MEFs.
(g) Graph showing the mean maximum [Ca2+]m in response to ATP (1 mM) in MEFs (n= 3; ***Po0.001). (h) Representative traces showing ATP-induced Ca2+ transients in
TSPO-silenced VDAC1− /− MEFs. (i) Bar chart showing the mean maximum [Ca2+]m in VDAC1
− /− MEFs; n= 4; **Po0.05. (j) Representative traces showing ATP-induced
Ca2+ transients MEFs exposed to PKI
Cell signalling regulation by TSPO
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contributes the impairment of the mitochondrial Ca2+ signaling
recorded when TSPO is overexpressed, we treatedMEFswith
a synthetic protein kinase inhibitor peptide (PKI) and re-
assessed mitochondrial Ca2+ levels in control and TSPO
knockdown cells.49
The PKA inhibitor (used as 1 mg/ml), which binds the free
catalytic subunit of PKA and prevents phosphorylation of the
kinase targets,49 normalized the differences in mitochondrial
Ca2+ transients (Figure 4j) indicative of active role by the
VDAC phosphorylation.
TSPO regulation of ACBD3/PKA mitochondrial recruit-
ment and VDAC1 phosphorylation. In light of the above
results, we examined the mitochondrial recruitment of both
the ACBD3 and PKA. In mitochondrial fractions isolated from
TSPO-overexpressing cells, we observed an increase of both
ACBD3 and PKA, as shown by immunoblotting experiments
reported in Figure 5a with the corresponding band density
analysis in Figure 5c (ACBD3, Control: 1.63±0.19; +TSPO:
2.72±0.07; PKA, Control: 1.08±0.09; +TSPO:3.13± 0.20;
TSPO, Control: 1.03± 0.19; +TSPO: 1.38±0.05). The
analysis of cytosolic fractions is shown in Figure 5b with
band density analysis in Figure 5d (ACBD3, Control:
0.57±0.03; +TSPO: 0.75± 0.02; PKA, Control: 0.85± 0.02;
+TSPO: 0.78± 0.05). The same analysis was repeated in
mitochondrial fractions of SH-TSPOkd cells (Figures 5e
and f) that showed a significant decrease in accumulation
of both ACBD3 (Control: 1.00±0.00; −TSPO: 0.39± 0.13)
and PKA (Control: 1.00±0.00; −TSPO: 0.40±0.20), com-
pared with WT SH-SY5Y (Figure 5f).
VDAC1 phosphorylation was tested by probing the
co-immunoprecipitated TSPO and VDAC1 with anti-phospho-
serine/threonine/tyrosine (Figure 5g) showing that VDAC1
was indeed phosphorylated more when TSPO is over-
expressed (+TSPO, 1.22± 0.11) and significantly less in
−TSPO conditions (−TSPO, 0.68±0.04) compared with
Control (Figure 5h). Further evidence for specific PKA
involvement in this process of post-translational modification
of VDAC1 was obtained by comparing the PKA translocation
in WT and VDAC1− /− cells (Supplementary Figure 4e). In
WT cells under oxidative stress, PKA readily accumulates on
mitochondria, whereas in VDAC− /− cells this is abolished. In
the same conditions, the mitochondrial portion of PKCε
remains unaltered indicative of a PKA-specific event
(Supplementary Figure 4f).
Glutamate induces TSPO expression and accumulation
of ROS paralleled by mitochondrial recruitment of the
ACBD3/PKA complex. In vivo imaging analysis had pre-
viously shown that TSPO accumulates in aged states of the
brain;6 here, by sampling brain protein extracts from wild-type
mice at 18 months, we reconfirmed the positive correlation
between ageing and TSPO (1 month: 0.11±0.02; 4 months:
0.23±0.05; 12 months: 0.53±0.04; 18 months: 0.72± 0.02;
Figure 6b).
The aged brain is highly sensitive to glutamate-induced
toxicity and we therefore explored the TSPO-coordinated
molecular cascade in SH-SY5Y cells challenged with gluta-
mate to provide in vitro evidences of a pathophysiological
stress condition known to exert cytotoxicity exploiting both
Ca2+ and ROS.50 Following glutamate application (4 mM,
acute), an increase in ROS production was immediately
detected (Figure 6c, Supplementary Figure 4a), abolished in
−TSPO cells (WT basal: 1, NSC basal: 0.88± 0.14, −TSPO:
0.17±0.08, WT+glutamate: 1.45± 0.24, NSC+glutamate:
1.69±0.22, −TSPO+glutamate: 0.43± 0.07, n=5). Corre-
spondingly, in these cells, glutamate-induced cell death
(20 mM, 8 h) was far lower (Figure 6d). In keeping with this,
VDAC suppression as well as PKI treatment in TSPO
expressing cells did mediate the same protective outcome
(untreated: 0.19±0.06, NSC: 1±0.09, −VDAC: 0.61± 0.04,
−TSPO 0.68±0.03, −TSPO±VDAC: 0.67± 0.03, vehicle:
1± 0.00, +PKI: 0.61±0.05, n=3).
The detrimental effect of glutamate in WT SH-SY5Y was
paralleled by TSPO, ACBD3 and PKA accumulation in
mitochondrial fractions (Figure 6e) suggesting a pathophysio-
logical adaptation following stress-induced TSPO expression
(fold increase as seen in Figure 6f, TSPO: 3.2±0.35, ACBD3:
1.2± 0.021, PKA: 1.18± 0.018).
As a further control, we tested MEFs stably knocked out for
PKCε (PKCε− /−) in which TSPO expression is largely
impaired.51 In these cells, glutamate led to negligible TSPO
upregulation and abolished mitochondrial accumulation of
ACBD3 and TSPO (Supplementary Figures 4b–d).
Finally, to corroborate the pathway further, we pursued a
pharmacological approach using U0126 (10 μM×48 h), a
highly selective inhibitor of the extracellular signal-regulated
kinase (ERK) to prevent stress-induced transcription of
TSPO51 (Figure 6g). U0126 prevents the mitochondrial
accumulation of TSPO when co-administrated with
glutamate on neuronal cells (Figures 6g and h; glutamate
+UO126, TSPO: 0.56± 0.09, PRKACA: 0.79±0.11).
Similarly, the mitochondrial accumulation of PKA is impaired
too implying an overall inhibition of the pathway (Figures 6g
and h). Hence, we generated the working model proposed in
Figure 7.
Discussion
Mitochondrial Ca2+ homeostasis is crucial for balancing cell
survival and death.52 The regulatory mechanisms of mito-
chondrial Ca2+ uptake across the IMM are especially
important for the regulation of ATP synthesis, mitochondrial
fission–fusion dynamics and the generation of reactive oxygen
species.53,54 Mitochondrial Ca2+ influx is regulated by a single
transport mechanism, the mitochondrial Ca2+ uniporter
(MCU);42 although additional elements can influence the
kinetics and efficiency of mitochondrial Ca2+ uptake.39,44,55
Among these, the voltage-dependent anion-selective chan-
nels, which shuttle Ca2+ andmetabolites across the OMM, are
of immediate interest given the interaction with TSPO3,17 and
the latter being an indicator of cell and tissue pathology6
recently linked to defective mitochondrial autophagy.17
Here we demonstrate that mitochondrial TSPO reduces the
transfer efficiency of Ca2+ into the organelle via VDAC1 and
this is observed both in human, murine and canine cells,
suggesting a conserved mechanism for mitochondrial Ca2+
adaptation. Furthermore, having recorded identical signaling
pattern in microglial cells (Supplementary Figures 2f–h), the
activation of which underlies brain conditions imaged by
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Figure 5 TSPO recruits ACBD3 and PKA to mitochondria and regulates VDAC1 phosphorylation. (a) Immunoblot of mitochondrial and (b) cytosolic extracts from control and
+TSPO MEFs run in duplicate with antibodies indicated on the right. (c) Bar charts showing the mean band density of ACBD3, PKA, TSPO normalized to ATPB5 in mitochondrial
fractions (n= 4) and (d) ACBD3, PKA normalized to ACTB in cytosolic fractions. (e) Immunoblot analysis of mitochondrial ACBD3 and PKA in SH-TSPOkd. (f) ACBD3, PKA,
TSPO normalized to SDHA in mitochondrial fractions (n= 4). (g) Immunoprecipitation of VDAC from SH-SY5Y cells in TSPO-modulated conditions. The lower section (input 5%)
western blotted with VDAC1 and TSPO antibodies. The upper section of the blot (IP) shows phosphorylated VDAC1. (h) Bar chart showing the mean band density of
α-phosphoserine/threonine/tyrosine according to TSPO expression, normalized to input VDAC1 (n= 3; *Po0.05, **Po0.01, ***Po0.001)
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TSPO,56 implies a likely outcome on the pro-inflammatory
intracellular pathways (e.g., Nf-κβ) mastered by the Ca2+ and
ROS signaling homeostasis.57
TSPO overexpression deregulates mitochondrial Ca2+
uptake capacity and increases the maximum [Ca2+]c following
challenge with IP3 generating stimuli (Figures 2a–d,
Cell signalling regulation by TSPO
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Supplementary Figures 1b–e and 2a–d), and pharmacological
inhibition of Ca2+ retention by intracellular stores (Figures
2e–h). This is consistent with previous evidences obtained
with the endogenous TSPO ligand, hemin (iron protoporphyrin
IX), which limits mitochondrial Ca2+ accumulation in isolated
mitochondria by reducing VDAC conductance.16 Synthetic
TSPO ligands can also affect mitochondrial Ca2+ handling.15
TSPO leaves unaltered communication and connectivity
between the ER and mitochondria (Figures 3d–g) consistently
with previous data on mitofusin 1 and 2 levels that also remain
constant.17
The TSPO-mediated inhibition of mitochondrial Ca2+ uptake
occurs independently from the MCU too. The observed null
effect (Figure 4a), though, does not rule out that TSPO could
facilitate the activity of MCU by alimenting surrounding Ca2+
pools as knocking down both TSPO and MCU partially
restored the [Ca2+]m (Figures 4f and g).
The TSPO-mediated regulation of mitochondrial Ca2+
transients appears nonetheless depending on VDAC1
(Figures 4h and i) which is, in TSPO-dependent manner,
phosphorylated by the PKA recruited to the mitochondrion in
complex with ACBD3 (Figures 5a–f). VDAC1 phosphorylation
results in diminishing its conductance for Ca2+ (Figures 5g
and h).46,58
Interestingly, high PKA activity is reported to promote
mitochondrial elongation,58 by phosphorylating DRP1 at
serine 656,59 which is in apparent contrast with our observa-
tions on mitochondrial structure (Figure 5a). It must, none-
theless, be noted that TSPO also promotes a rise in [Ca2+]c,
which could activate Ca2+ kinases (Cdk1/cylin B or
CaMK)59–61 thus phosphorylating DRP1 at alternative sites
(e.g., ser-585 and ser-616) antagonizing, and not compensat-
ing, for PKA-induced inhibitory phosphorylation at ser-656.
Non-physiological rises in [Ca2+]c can nonetheless predis-
pose the cells to oxidative stress via activation of NOXs.
Experiments performed using the pharmacological NOX
enzyme inhibitors DPI, Apocynin, as well as KN93 that instead
targets CaMKII (Figures 1d–f), suggest this to be the most
likely signaling pathway via which TSPO triggers intracellular
oxidative stress in mammalian cells. This was confirmed by
gene expression analysis in which a correlation between
TSPO expression and the Ca2+-regulated isoform of NOXwas
observed (Figures 1j–l). As this isoform of the NOX family is
implicated in various pathological conditions as well as the
regulation of redox-sensitive signaling pathways upstream of
TSPO, such as ERK1/2, it could well represent the pivotal
means for the feed-forward mechanism – hypothesized in
precedence17 – whereby the expression of TSPO increases
during redox stress and to which it directly contributes. This
Ca2+-regulated mechanism of ROS accumulation could
explain the TSPO-mediated inhibition of oxidative stress-
sensitive processes such as the prevention of PARK2-
mediated mitophagy.17
The increased rate of cell death recorded in vitro in TSPO-
overexpressing cells exposed to glutamate, accounts for
greater susceptibility to high dosage of the neurotransmitter
(Figure 6), and given the progressive, age-dependent accu-
mulation of TSPO in the brain (Figures 6a and b), it would be
worth exploring whether this could act as a predictive
molecular signature to neurodegeneration. The mitochondrial
accumulation of ACBD3 levels, which parallel those of TSPO
(Figures 6e and f), has been previously linked to NDMA
neurotoxicity.62,63
Equally, even though the recruitment of cytosolic elements
on mitochondria has been previously reported,64 (Figure 6c)
never before was this ascribed to master mitochondrial Ca2+
uptake.
An untested scenario is whether the overexpression of
TSPO consequent acute intoxication (e.g., high glutamate
level), or similar forms of toxicological stress, may prime
alternative ways of cell death in which the imbalance of redox
homeostasis has a great part. It is indeed intriguing to think
that TSPO as a priming element of the oxytosis, of the above-
mentioned typologies of cell death, is the prototype.65,66 We
indeed reported that the sole TSPO overexpression depletes
intracellular GSH level in MEFs,17 thus implying that protein
could be a molecular conduit in this very process of cell
execution, and future studies shall clarify on this.
Neuronal demise induced by the overstimulation of
glutamate receptors is dependent on a sustained increase in
[Ca2+]i
67 in which mitochondria are implicated as buffering
compartments capable of modulating the degree of cellular
Ca2+ tonicity.68 Molecules that regulate mitochondrial Ca2+
dynamics may indeed prove fundamental in reducing the
severity of cellular insults to prevent or delay onset of
neurodegeneration69 as well as regulating other processes,
such as Autophagy, which are influenced by the Ca2+
tonicity.70
TSPO may therefore represent part of an innate stress
response pathway to prevent accumulation of Ca2+ in the
mitochondria during cytotoxic insults. However, in turn, this
may lead to the accumulation of both short- and long-lived
redoxmolecules, which would underline detrimental effects for
which the overexpression of TSPO could represent both a
diagnostic and therapeutic target.71
Materials and Methods
Cell culture and transfection. Mouse embryonic fibroblast cells
(MEFs)17,45— a kind gift from Professor William Craigen (Bayer College of
Medicine Medical Genetics Laboratories, Houston, TX, USA) and canine mammary
Figure 6 Glutamate-induced stress response upregulates TSPO recruiting the ACBD3–PKA complex on mitochondria. (a) TSPO expression level in brain lysates isolated
from mice at different time points − 1, 4, 12 and 18 months. (b) Data quantification (n= 2). (c) Bar chart showing the rate of increase in DHE fluorescence intensity in control,
non-silencing control and TSPO-modulated cells treated with glutamate (4 mM, acute; ⩾ 15 cells per field of analysis, Po0.01). (d) Bar chart showing cell death induced by
glutamate in VDAC- or TSPO-modulated cells, or cells treated with PKI (n= 4, Po0.05). (e) Representative immunoblot of mitochondrial and cytosolic fractions isolated from
SH-SY5Y treated with glutamate. Antibodies are indicated on the right. (f) Bar chart showing band density changes in mitochondrial distribution of TSPO, ACBD3 and PKA over
the duration of glutamate treatment, normalized to ATPB5. (g) Representative immunoblot of mitochondrial and cytosolic fractions of neurons challenged with glutamate during
co-treatment with U0126. (h) Bar charts reporting the relative quantification of the proteins expression profile (*Po0.05, **Po0.01, ***Po0.001)
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gland epithelial cells (CF35), SH-SY5Y neuroblastoma (ATCC, Manassas, VA, USA)
were maintained in a temperature-controlled, humidified incubator at 37 °C with 5%
CO2 (Hera Cell 240, Thermo Scientific, Essex, UK) in Dulbecco’s modified Eagle
medium (DMEM; Life Technologies, 11995065) supplemented with 10% fetal bovine
serum (FBS; Life Technologies, 10082147), 100 U/ml penicillin and 100 mg/ml
streptomycin (Life Technologies, 15140122).
TSPO was depleted using siRNA before experimentation as described
previously.17 To knock down MCU in MEFs, we used siRNA 5′-GCCA
GAGACAGACAATACT-3′.42 As a control for these studies, a non-silencing siRNA
sequence (AllStars Negative Control, Qiagen, 1027281) was transfected. For
overexpression studies, a pcDNA3.1 (− ) construct containing the full murine TSPO
cDNA open reading frame, was transfected; the empty vector was used as a control in
this instance. The cells were transfected using a standard Ca2+ phosphate method.
All experiments with modulation of TSPO expression were performed 48 h post
transfection.
Quantitative real-time PCR. One microgram total RNA was reverse
transcribed using iScript select cDNA synthesis kit (Bio-Rad). Nox/Duox enzyme
expression was determined via quantitative real-time PCR (qPCR) using gene-
specific Taqman gene expression assays (Applied Biosystems, Foster City, CA,
USA). Each reaction was performed in a final volume of 11 μl containing 50 ng
cDNA, 0.55 μl 20 × gene-specific Taqman assay and 5.5 μl 2 × ABI FAST
Mastermix (Applied Biosystems). Expression was normalized to the endogenous
reference TATA-Box-binding protein (TBP) (forward 5′-CACGAACCACGGCA
CTGATT-3′; reverse 5′-TTTTCTGCTGCCAGTCTGGAC-3′; probe 5′-FAM-
TCTTCACTCTTGGCTCCTGTGCACA-TAMRA-3′). For TBP, the primers were
added to a final concentration of 900 nM, and the final probe concentration was
150 nM. Real-time PCR conditions were as follows: one cycle of hold at 50 °C for
2 min and one cycle of polymerase activation at 95 °C for 20 s, followed by 40
cycles of 95 °C for 3 s and 60 °C for 30 s on an ABI Prism 7500 Fast RT-PCR
System (Applied Biosystems). Amplifications were performed in duplicate with the
exception of Nox5, which was performed in quadruplicate due to its relative low
abundance. Fold change in gene expression was calculated according to the
2−ΔΔCT method (Livak and Schmittgen 2001 PMID: 11846609) from four
independent experiments.
NOX5 lentiviral knockdown. Lentiviral particles for scrambled control and
two different Nox5 small hairpin RNA (shRNA) sequences were generated in
HEK293FT cells (Invitrogen, Carlsbad, CA, USA) using the packaging plasmids
pMD2.G and psPAX2 (Addgene; Cambridge, MA, USA) and the lentiviral vector
pLKO.1 containing Nox5-specific shRNA (clone ID TRCN0000046099 or
TRCN0000046101 from Dharmacon, GE Lifesciences, USA) or scrambled control
(Addgene plasmid 1864). Lentiviral titer was determined via application of serially
diluted lentivirus-containing supernatant to U2-OS cells. After 24 h, puromycin
selection was initiated (0.5 μg/ml), and 6 days later, colonies counted following
staining with 1% crystal violet (Sigma-Aldrich, St. Louis, MO, USA). For lentiviral
infection, 100 000 SH-SY5Y cells were seeded in 25 cm2 flasks. The next day,
culture medium containing 8 μg/ml hexadimethrine bromide (Sigma-Aldrich) and
lentiviral particles at a multiplicity of infection of 40 was added to the cells. The
infection was repeated again 48 h later. Puromycin selection (0.5 μg/ml) was started
48 h after the second infection, and the concentration doubled at 48 h intervals until
the final selection concentration (2 μg/ml) was reached. Three independent
Figure 7 Working mechanism for TSPO-mediated regulation of mitochondrial Ca2+ handling. Overexpression of TSPO results in the recruitment of ACBD3 and PKA and
corresponds with an increase in VDAC1 phosphorylation. Ca2+ released from internal stores accumulates in the cytosol, unable to diffuse across the outer mitochondrial
membrane through VDAC1. The increase in cytosolic Ca2+ activates NOX5, via CaMKII leading to altered REDOX balance
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experiments were performed generating three independent polyclonal sublines for
each shRNA.
TSPO knockdown in SH-SY5Y. This was achieved using the pGIPZ
shRNA vector: clone ID V3LHS_331646, target sequence: 5′-TGAGTGTGGTCGTG
AAGGC-3′, purchased from Open Biosystems (Huntsville, AL, USA).
Non-silencing shRNA vector sequences (mature antisense): V3LHS_331648:
5′-ACGCAGTAGTTGAGTGTGG-3′; V3LHS_331650: 5′-TCTGCAGGCCGGCGTA
CCA-3′.
Transfection was performed using standard Ca2+ phosphate-based protocol,72 and
the cells maintained for 2 weeks in media supplemented with 3 μg/ml puromycin
(SERVA Electrophoresis GmbH) for the selection of transfected (GFP-positive) cells.
TSPO downregulation in SH-TSPOkd cells was confirmed by western blot analysis:
SH-SY5Y and SH-TSPOkd cells were washed in PBS and collected by gentle
scraping in ice-cold RIPA buffer. Protein concentration was estimated using the
Bradford reagent. Following this, 50 μg of protein was mixed with Laemmli sample
buffer and boiled at 95 °C for 2 min. The samples were resolved by sodium-dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to
nitrocellulose membranes. The blots were probed with antibodies diluted in 1%
bovine serum albumin in tris-buffered saline with 0.1% Tween-20 (TBS-T) overnight
(4 °C). Then, they were detected using horseradish peroxidase-conjugated
secondary antibody (1 : 2000; Cell Signaling, Danvers, MA, USA; 60 min at room
temperature (RT) in 5% non-fat milk) and an enhanced luminescence kit (Amersham
Pharmacia Biotech, Piscataway, NJ, USA). The antibodies used were rabbit
monoclonal anti-TSPO (Abcam, UK; ab109497), mouse monoclonal anti-GAPDH
(Abcam ab9482), goat anti-rabbit IgG and goat anti-mouse IgG horseradish
peroxidase-conjugated secondary antibodies (Bio-Rad).
Immunoblotting analyses. For whole-cell lysates, the cells were collected
and resuspended in 1 ml of lysis buffer, 50 mM Tris (Sigma T6066) pH 8.0; 150 mM
NaCl; 1% Triton-X (Sigma, T9284), protease inhibitor (Roche, UK, 04693132001)
and left on ice for 20 min. The cell debris was removed by centrifugation at 17 000
G for 20 min. For mitochondrial isolation, 500 μl sucrose isotonic fractionation buffer
(250 mM sucrose; 20 mM HEPES (pH 7.4); 10 mM KCl; 1.5 mM MgCl2 (M4880);
1 mM EDTA (Sigma, E6758); 1 mM EGTA (Sigma, E3889); protease inhibitor) was
added to confluent cells growing on 10 cm plates. The plates were scraped
immediately and the cell suspension was then passed through a 26-gauge needle
12 times before centrifuging at 700 × g for 5 min. The resulting supernatant was
subjected to a further centrifugation at 10 000 × g to obtain the mitochondrial pellet.
The proteins were resolved on 12% SDS-PAGE gels, transferred onto nitrocellulose
membranes and detected with α-TSPO (Abcam ab109497), ATPB5 (Abcam
ab14730), ACBD3 (Abcam ab131592), ACTB (Abcam ab8226), PRKACA (Abcam
ab76238), Cyt-C (Abcam ab110325) α-GAPDH (Abcam ab9482).
Immunoprecipitation studies. TSPO expression in wild-type SH-SY5Y
cells was modulated by transfection with TSPO cDNA or anti-TSPO siRNA. The
cells were washed once in PBS then lysed by suspension in lysis buffer (20 mM
Tris, 100 mM NaCl, pH 7.5) at 4 °C for 30 min. The unbroken cells and nuclei were
removed by centrifugation at 2600 × g for 5 min. The supernatants were
immunoprecipitated using a dynabead co-immunoprecipitation kit (Invitrogen,
14321D) following the manufacturer’s instructions. Briefly, for each reaction, 5 μg
of α-VDAC antibody was coupled to 1 mg of dynabeads using the provided coupling
solutions overnight at 37 °C. For negative control conditions, the beads were
subjected to the same procedure in the absence of VDAC antibody. The
supernatants were mixed with the antibody-coupled beads and incubated for 1 h at
4 °C with end-over-end mixing. Boiling the washed beads in SDS-PAGE loading
buffer eluted complexes. The proteins were resolved on 12% SDS-PAGE gels,
transferred onto nitrocellulose membranes and detected with α-Phosphoserine/
threonine/tyrosine antibody (Abcam 15556), α-VDAC (Abcam ab14743) α-TSPO
(Abcam ab109497) and α-GAPDH (Abcam ab9482) antibodies.
Immunocytochemistry. Primary co-cultures of neurons and astrocytes were
fixed in 4% PFA (15 min, RT) and permeabilized in 0.5% Triton-X (15 min, RT).
Blocking was carried out for 1 h at RT in 10% Goat Serum (Life Technologies,
16210064) and 3% BSA in PBS. Primary antibody incubations were conducted
overnight for 16 h at 4 °C in blocking solution in a humidified chamber. After a
further wash step, secondary antibodies were incubated for 1 h in blocking
solution at RT, before a final wash step. Finally, the cells were mounted on slides
with 4′,6-diamidino-2-phenylindole (DAPI) mounting medium (Abcam, ab104139)
and sealed.
Ca2+ recordings. The mtAEQmut transfected cells grown on glass coverslips
were incubated with 5 μM coelenterazine (Promega, Madison, WI, USA, S2001) for
2 h in recording medium (RM) supplemented with 1 mM CaCl2.
17 Glass coverslips
were then transferred to the thermostatted perfusion chamber of a custom-built
luminometer (Cairn Research, Faversham, Kent, UK). Agonists and other drugs, as
indicated in the figure legends, were added to the same RM. The experiments were
terminated by lysing cells with 100 μM digitonin in a hypotonic Ca2+-rich solution
(10 mM CaCl2 in H2O), so as to discharge the remaining aequorin pool. The
aequorin luminescence was captured by a photon-counting board and the data were
calibrated into [Ca2+] values using a computer algorithm.73
Alternatively, TSPO knockdown cells on glass coverslips were loaded with 8 μM
rhod-2 AM (Life Technologies, Paisley, UK) and 0.005% pluronic in modified Kreb’s
Ringer Buffer (mKRB; 125 mM NaCl; 5 mM KCl; 1 mM MgSO4; 1 mM Na2HPO4;
5.5 mM glucose; 20 mM NaHCO3; 2 mM L-glutamine; 20 mM HEPES supplemented
with 1.8 mM CaCl2; pH 7.35) for 35 min at 37 °C.
74 Following loading, the cells were
washed four times in mKRB before imaging. For cytosolic Ca2+, the cells were loaded
with 5 μM Fluo-4 AM (Life Technologies, Paisley, UK) and 0.02% pluronic in mKRB for
30 min at 37 °C. The cells were immediately transferred to a Leica SP5 Confocal
microscope for imaging where they were maintained at 37 °C. A field of transfected
cells was selected (either YFP positive for mitochondrial Ca2+ or mtRFP positive for
cytosolic Ca2+) and using a ×40 objective, a time series was then set up so that a new
image was acquired every 1 s to ensure the transient Ca2+ increase is captured. For
mitochondrial Ca2+ accumulation, the 543 nm laser was used to excite Rhod-2 (red)
and for cytosolic Ca2+, the 488 nm laser was used to excite Fluo-4 (green). After
continuous recording for approximately 30 s, ATP was added (100 μM–1 mM). The
increase in Ca2+ concentration induces a sharp rise in fluorescence intensity of both
Fluo-4 and Rhod-2.74 When the signal returned to near starting values, ionomycin
(Sigma, I3909) was added (0.5 μM). The application of ionomycin eliminates any
remaining Ca2+ gradient between all membranes, thus saturating available Fluo-4/
Rhod-2. Recording was stopped when the intensity of the Ca2+ dye reached a
plateau. The data were normalized to the ionomycin response by using the equation
(x−min x)/(max x−min x).
Reactive oxygen species recording. To quantify cellular levels of ROS17
in this study, the commonly used fluorescent dye, dihydroethidium (DHE), was used.
DHE is sensitive to O2
− (superoxide) and may be oxidized. Once oxidized, DHE
binds to DNA, which results in the amplification of the red signal within the nucleus.
The rate at which the signal increases in intensity is dependent on cytosolic levels of
O2
−, thereby enabling the quantification of ROS levels within the cell. The cells
grown on glass coverslips were transfected with mitochondria-targeted GFP
(mtGFP) and TSPO expression silenced. A field of healthy transfected cells was
selected and 5 μM DHE (Life Technologies, D11347), diluted in RM, was added.
The rate of increase in fluorescence intensity was measured through continuous
recording for at least 10 min.
Mitochondrial membrane potential (ΔΨm) analysis. The cells,
co-transfected with YFP were loaded with 50 nM tetramethyl rhodamine methyl
ester (TMRM) (Sigma, T5428) in HEPES-buffered salt solution (156 mM NaCl;
3 mM KCl; 2 mM MgSO4; 2 mM CaCl2; 10 mM glucose; 10 mM HEPES). The cells
were allowed to equilibrate the dye for at least 30 min at room temperature before
they were transferred to a Zeiss LSM 510 confocal microscope (×40 objective) for
imaging. Mitochondrial ROIs were demarcated and the corresponding TMRM
fluorescence intensities calculated by removing background signal through
thresholding as previously explained.72,74
Mitochondrial morphology analysis. The CF35 cells were transfected
with mtGFP to visualize mitochondria. To assess mitochondrial morphology, the
mitochondrial form factor (FF) and aspect ratio (AR) were calculated as described
previously.74 For measuring ER-mitochondria connectivity, MEFs transfected with
mtRFP were loaded with ER tracker green (Life Technologies, E34251; 1 μM) for
30 min. An object-based estimate of the co-localization events between ER-green and
mtRFP channel 3D z-stacks was obtained by calculating Manders’ coefficients (M1 and
M2).74 These are based on the Pearson’s correlation coefficient but do not consider
average intensity values and vary from 0 (non-overlapping) to 1 (100% co-localization).
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Preparation of brain tissue protein lysates. The 1-, 4-, 12- and
18-month-old C57/BL6 mice were killed by cervical dislocation and brains harvested
on ice. The frontal cortex tissue was excised by forceps and lysed in a specific lysis
buffer containing 1% Triton X-100 (Applichem Panreac), 320 mM sucrose (Sigma-
Aldrich), 50 mM Tris-HCL pH 7.5, 50 mM NaCl (Sigma-Aldrich), supplemented with
protease inhibitor cocktail solution (Sigma-Aldrich). Tissue was disrupted by
sonication, followed by 30 min incubation on ice to allow protein solubilization. Next,
the lysates were cleared by centrifugation for 20 min at 13 000 r.p.m. at 4 °C. The
supernatants were then collected and protein concentration measured using Brad-
ford method (Applichem Panreac, Germany). The protein samples were stored at
− 80 °C before western blot analysis.
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